Search

Your search keyword '"Garg, Parveen K"' showing total 6 results
Start Over Author "Garg, Parveen K" Publisher sage publications
6 results on '"Garg, Parveen K"'

3. Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults: The Cardiovascular Health Study

Author

Garg, Parveen K, primary, Biggs, Mary L, additional, Barzilay, Joshua, additional, Djousse, Luc, additional, Hirsch, Calvin, additional, Ix, Joachim H, additional, Kizer, Jorge R, additional, Tracy, Russell P, additional, Newman, Anne B, additional, Siscovick, David S, additional, and Mukamal, Kenneth J, additional

Published
2019
Full Text
View/download PDF

4. Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease in a multi-ethnic cohort: The Multi-Ethnic Study of Atherosclerosis

Author

Garg, Parveen K, primary, Jorgensen, Neal W, additional, McClelland, Robyn L, additional, Jenny, Nancy S, additional, Criqui, Michael H, additional, Allison, Matthew A, additional, Greenland, Philip, additional, Rosenson, Robert S, additional, Siscovick, David S, additional, and Cushman, Mary, additional

Published
2016
Full Text
View/download PDF

6. Lipoprotein-associated phospholipase A 2 and risk of incident peripheral arterial disease in a multi-ethnic cohort: The Multi-Ethnic Study of Atherosclerosis.

Author

Garg PK, Jorgensen NW, McClelland RL, Jenny NS, Criqui MH, Allison MA, Greenland P, Rosenson RS, Siscovick DS, and Cushman M

Subjects
Aged, Aged, 80 and over, Ankle Brachial Index, Biomarkers blood, Chi-Square Distribution, Female, Humans, Incidence, Linear Models, Logistic Models, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Peripheral Arterial Disease diagnosis, Prospective Studies, Risk Assessment, Risk Factors, Time Factors, United States epidemiology, 1-Alkyl-2-acetylglycerophosphocholine Esterase blood, Peripheral Arterial Disease blood, Peripheral Arterial Disease ethnology
Abstract

Prospective studies supporting a relationship between elevated lipoprotein-associated phospholipase A 2 (Lp-PLA 2 ) and incident peripheral arterial disease (PAD) are limited. We evaluated the association of Lp-PLA 2 with incident PAD in a multi-ethnic cohort without clinical cardiovascular disease. A total of 4622 participants with measurement of Lp-PLA 2 mass and Lp-PLA 2 activity and an ankle-brachial index (ABI) between 0.9 and 1.4 were followed for the development of PAD (median follow-up = 9.3 years), defined as an ABI ⩽0.9 and decline from baseline ⩾0.15. There were 158 incident PAD events during follow-up. In adjusted logistic regression models, each higher standard deviation of both Lp-PLA 2 activity and mass did not confer an increased risk of developing PAD [odds ratios, (95% confidence intervals)]: 0.92 (0.66-1.27) for Lp-PLA 2 activity and 1.06 (0.85-1.34) for mass. Additionally, no significant interaction was found according to ethnicity: p=0.43 for Lp-PLA 2 activity and p=0.55 for Lp-PLA 2 mass. We found no evidence of an association between Lp-PLA 2 and incident PAD.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results